1. Introduction {#s0005}
===============

The aloe species are commonly applied for ethnomedicine plus pharmacological potential for evaluate various ailments, injuries, digestive ailments, infection also anti plasmodial, antimicrobial, anthelmintic in addition anti-inflammatory, activities of particular of the species has been established provided that reason for their use in ancestral medicine ([@b0115], [@b0030]). The Aloe extracts are medically important and their application have been used to treatment of skin cancer, arthritis, eczema, heart attacks, burns, psoriasis, digestive problems, leukemia, high blood pressure and diabetes ([@b0055], [@b0075]). The Aloe emodin (AE), a naturally derived from plant anthraquinone, is described to have potential antiproliferative activity in different cancer cell lines ([@b0095]). As diverse of *Aloe* species would have different phytochemical compounds due to interspecies difference and changing soil conditions as well as climate, direct correlation of biological activity would be incorrect ([@b0040], [@b0075]) therefore essential to concentrate on aloe species particularly *Aloe pseudorubroviolacea* and *Aloe castellorum* due to no previous studies recorded.

United States is recorded that second leading cause of death by cancer related ([@b0025]). The Colorectal cancer (CRC) recorded that the third utmost common cancer in the worldwide. [@b0120] as well as the second most common cancer through CRC in Saudi Arabia ([@b0080], [@b0125]). In position first among men (10.6%) and woman among third (8.9%) ([@b0010]), the death rate from CRC is 8.3%. [@b0045] in Saudi Arabia stated that World Health Organization (WHO). Furthermore, retrieved data from the Saudi Cancer Registry (SCR; <http://www.scr.org.sa/>) showed rising in CRC occurrence between 2001 and 2006, and very nearly increase twofold between 1994 and 2003. Furthermore, Patients in Saudi are likely to present at a more advanced stage and at a younger age matched with Western countries ([@b0020], [@b0090], [@b0080]). Hence we attempted to evaluate phytochemical constituents from the methanolic extracts of medicinal plants *Aloe castellorum* and *Aloe pseudorubroviolacea* with cytotoxic activity of Human Cancer cell line HCT 116.

2. Materials and methods {#s0010}
========================

2.1. Plant collection and processing {#s0015}
------------------------------------

The selected plant leaves were dried at room temperature. Appropriate quantities (500 mg) of the leaves and in plant were using methanolic extraction with 5 times. The collected methanol extract was centrifuged at 5000*g* for 10 min at room temperature, then the supernatant of methanol was prudently pipetted out transferred to sterilized eppendorf tubes without disturbing the inter-phase residues for further analysis. ([@b0005]).

2.2. Cancer cell culture {#s0020}
------------------------

The colon cancer cells HCT-116 were acquired from National Centre for Cell Science, Pune, India. Cells were inoculated in 10% fetal bovine serum and 1% antibiotics (penicillin, streptomycin and amphotericin) supplied Dulbecco's Altered Eagles Medium (DMEM), used incubated with humidifier at 37 °C in a moisturized atmosphere provided with 95% and 5% Carbon dioxide and air incubation. The leaf extracts of *Aloe castellorum* and *Aloe pseudorubroviolacea* was completely dissolved in 1% DMSO prior treatment with cell.

2.3. Cytotoxicity of plant extracts *Aloe castellorum* and *Aloe pseudorubroviolacea* against HCT-116 cells {#s0025}
-----------------------------------------------------------------------------------------------------------

The cytotoxicity of extracts *Aloe castellorum* and *Aloe pseudorubroviolacea* was evaluated by employing the yellow tetrazolium MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) MTT analyze based on the reduction of MTT through action of mitochondrial reductase enzyme which presents in viable cells. The amount of reduction of MTT to formazan in extracts *Aloe castellorum* and *Aloe pseudorubroviolacea* treated and untreated cells were directly proportional to the number of viable cells, it was assessed by taking absorbance values by dissolving the formazan with DMSO. In brief, cells (1 × 105) were plated as well as incubated for 24 h at 37 °C in a humidified condition used 96 well plates. After complete incubation the old medium was aspirated without disturbing cells then the cells were tested with different concentrations (5, 10, 20, 30, 40, 50, 60, 70 and 80 µg per ml) of extracts *Aloe castellorum* and *Aloe pseudorubroviolacea* dissolved DMEM, the plate was kept in same incubation condition. After incubation, 100 µL of MTT reagent of 5 mg/mL in PBS was subsequently added into each individual well further, the plates were incubated for 24 h at 37 °C. The resulting formazan was dissolved by adding 100 µL of DMSO and the absorbance of the reactant solution was recorded at 595 nm wavelength using a multiwell plate reader (Tecan Multimode Reader, Austria). The concentrations of the test sample which showed 50% of cell death was then calculated ([@b0050]).

2.4. Assessment of apoptotic morphological changes {#s0030}
--------------------------------------------------

The treated and untreated HCT-116 cells by staining with Ethidium Bromide (EtBr) plus Acridine Orange (AO) dye was used to determine the apoptotic cells morphological changes by extracts *Aloe castellorum* and *Aloe pseudorubroviolacea* ([@b0070]). The cultivated cells were in 6-well plate (3 × 104 cells/well) and treated with extracts of *Aloe castellorum* and *Aloe pseudorubroviolacea* at various dosage ranges (25, 50 and 75 µg) for 24 h. The cells were fixed in (methanol: glacial acetic acid (3:1)) for 30 min at 4 °C. The cells were stained with (Ethidium Bromide (EtBr) plus Acridine Orange (AO) 1:1 ratio) and left for 30 min after washing cells with PBS. Consequently, washed the stained cells with Phosphate buffered saline and a FLoid cell imaging station (Invitrogen, USA) for observation. The apoptosis was assessed by counting the cells showing apoptosis features in the total number of cells observed in the microscopic field.

2.5. Measurement of intracellular ROS generation {#s0035}
------------------------------------------------

Intracellular ROS production in extracts of *Aloe castellorum* and *Aloe pseudorubroviolacea* treated and untreated HCT-116 cells were estimated through non-fluorescent probe DCFH-DA that can merely pass into the intracellular cell matrix, there it was oxidized into fluorescent dichlorofluorescein (DCF) by the action of produced ROS. Consequently, the fluorescence strength was comparatively proportional to the level of ROS production ([@b0060]). The HCT-116 cells were inoculated (1 × 106 cells/well) into 6-well plate, tested with various concentrations (25, 50 and 75 µg) of extracts *Aloe castellorum* and *Aloe pseudorubroviolacea* and placed in CO2 (5%) incubator for 24 h. Then the cells were exposed to 100 µL of DCFH-DA for 10 min at 37 °C. Fluorescence depth was estimated through excitation and emission filters fixed at 485 and 530 nm, respectively (Shimadzu RF-5301 PC spectrofluorometer). The results showed an increased percentage of fluorescence depth.

2.6. Determination of mitochondrial membrane potential {#s0040}
------------------------------------------------------

The assessment of mitochondrial membrane potential of treated and untreated HCT-116 cells was estimated by staining the cells with lipophilic cationic, Rhodamine-123 (Rh-123) dye ([@b0065]). The cells (3 × 10^4^ cells/well) were cultured in 6 wells plate and treated with various concentrations of extracts *Aloe castellorum* and *Aloe pseudorubroviolacea* (25, 50 and 75 µg) for 24 h. Then Rhodamine-123 fluorescent dye was added into treated and untreated cells and left for 30 min. The Mitochondrial membrane potential was qualitatively examined under a FLoid cell imaging station (Invitrogen, USA). Subsequently, the cells were harvested by Trypsinization of cells and the fluorescence strength was estimated at 485/530 nm wavelength under Spectrofluorometer (Schimadzu, USA). The positive control compared with results which maintained without treatment.

2.7. Assessment of level of reactive oxygen species (ROS) {#s0045}
---------------------------------------------------------

The reactive oxygen species (ROS) level was quantitatively assessed through the H2DCFDA staining method. For this, the colon cancer cell lines tested with extracts *Aloe castellorum* and *Aloe pseudorubroviolacea* were set with 70% ice-cold methanol. After that, incubation was done consuming 10 μL of H2DCFDA for 30 min at room temperature. The cells was measured through the fluorescence intensity using excitation wavelength of 480 nm also the emission wavelength of 530 nm through used a flow cytometer. The acquired date were analyzed by cyflogic software ([@b0110]).

2.8. Caspase-8, 9 and 3 activity assay {#s0050}
--------------------------------------

The Caspase-8, 9 and 3 activities were reflected through caspase assay kit, as per company's instruction the procedure was followed. Soon after that the colon cancer cells were loaded in (6 well plate) then treated with extracts of *Aloe castellorum* and *Aloe pseudorubroviolacea* then permitted to incubate for 24hr at CO2 incubator. Then, the cells were allowed to treat with appropriate caspase-8, 9 plus 3 reagents and incubated for 2 h in dark room followed by optical density for caspase-8, 9 and 3 were measured with a microplate reader at 400 or 405 nm.

2.9. Statistical analyses {#s0055}
-------------------------

The all experiments data were conducted in three independent replicated and the results were stated as the mean ± Standard Deviation (Mean ± SD) analyzing through one-way analysis of variance between the obtained values (ANOVA). Values of P \< 0.05 indicated the significant differences in data.

2.10. Molecular docking {#s0060}
-----------------------

Docking studies are key component to inspect the interaction, binding mode between compounds **9-octadecenoicacid**, **3-dodecanol** and the Musashi-1 (MSI1) protein via Autodockvina 1.1.2 ([@b0105]). The crystal structure of MSI1protein (PDB ID: 2RS2) was reserved from Protein Data Bank (<http://www.rcsb.org>). The 3D assembly of the compounds **9-octadecenoicacid** and **3-dodecanol** were achieved via ChemDraw Ultra 12.0 and Chem3D Pro 12.0 software. The input files for AutodockVina were created by using Autodock Tools 1.5.6 program package. The search grid of 2RS2 protein was fixed atcenter_x: −1.568, center_y: 0.832, and center_z: −4.286 with dimensions size_x: 20, size_y: 20, and size_z: 20 with spacing of 1.0 Å. The exhaustiveness value was set to 8. The other parameters were set to default for Vina docking and not mentioned. The compound having least binding affinity value is the best-scoring compound and the results were visually analyzed using Discovery studio 2019 program.

3. Results and discussion {#s0065}
=========================

3.1. Spectral characterization and structural elucidation of major compound {#s0070}
---------------------------------------------------------------------------

After chromatographic separation, the methanolic extracts of *Aloe castellorum* and *Aloe pseudorubroviolacea* were subjected to GS-MS analysis. The methanolic extract of *Aloe castellorum* contains around 20 chemical constituents ([Table 1](#t0005){ref-type="table"}) and the major compound is **9-octadecenoicacid** with the retention time value of 13.706. The methanolic extract of *Aloe pseudorubroviolacea* contains around 20 chemical constituents ([Table 2](#t0010){ref-type="table"}) and the major compound is **3-dodecanol** with the retention time value of 15.731. The Gas chromatogram and respective mass spectrum for major constituent of *Aloe castellorum* were shown in [Fig. 1](#f0005){ref-type="fig"} and [Fig. 2](#f0010){ref-type="fig"}. The Gas chromatogram and respective mass spectrum for major constituent of *Aloe pseudorubroviolacea* were shown in [Fig. 3](#f0015){ref-type="fig"} and [Fig. 4](#f0020){ref-type="fig"}.Table 1Phytochemical analysis of *Aloe castellorum* present by GC MS.Peak Report TICPeak\#R. TimeAreaArea%HeightHeight%A/HName17.76343,7430.7013,0960.733.341-dodecanamine N,N-dimethyl-(CAS)DI-METHYLDODECYLAMINE213.315375,1635.98156,7478.732.39METHYL 9-OCTADECENOATE313.410108,7531.7349,9092.782.18METHYL 9-OCTADECENOATE413.499529,0328.43228,82412.752.31Hexadecanoic acid, methyl ester (CAS) Methyl palmitate513.706907,05614.46332,08818.502.739-OCTADECENOIC ACID (Z) -613.788626,5859.99190,98310.643.289-octadecenoic acid (z) - (CAS) Oleic acid713.869440,0367.01112,2456.253.92Hexadecanoic acid (CAS) palmitic acid813.942128,8802.0551,1842.852.524, Nonenoic acid, methyl ester (CAS) methyl 4 nonenoate914.058237,9963.7932,6351.827.29Cyclohexanol, 3-methyl-(CAS) 3- Methylcyclohexanol1014.33653,9810.8615,7150.883.431 heptanol (CAS) HEPTANOL1114.439114,6691.8323,8451.334.811 heptanol (CAS) HEPTANOL1214.53257,0200.9117,8140.993.20Hexanoic acid, 2-methyl-(CAS) 2-Methylhexanoic acid1314.61999,1491.5841,1412.292.411,2-Cyclohexanedimethanol (CAS) CYCLOHEXAN, 1,2-BIS(HYDROXYMETHYL)1415.2841,503,54823.97285,68415.915.269,12\--Octadecadienoic acid methyl ester, (E,E)- (CAS) Methyl linolelaidate1515.474183,7022.9359,1063.293.112-Hexadecen-1-o1,3,7,11,15-tetramethyl-,\[R-\[R\*,R\*-(E)\]\]-(CAS)Phytol1615.552251,0934.0074,7724.173.36Hexadecanoic acid, methyl ester (CAS) Methyl palmitate1715.71779,3021.2620,0181.123.969,12\--Octadecadienoic acid (Z,Z)-, phenylmethyl1815.779111,0571.7723,2631.304.771,5-CYCLOOCTADIENE1917.291146,5612.3418,1431.018.08Propane, 2-methoxy-(CAS) Methyl isoprophyl ether2022.697275,8554.4047,9112.675.761-Pentanol, 4-methyl-2-propyl-(CAS) 2-PROPYL-4-METHYL-PENTANOL-16,273,181100.001,795,123100.00Table 2Phytochemical analysis of *Aloe pseudorubroviolacea* present by GC MS.Peak Report TICPeak\#R. TimeAreaArea%HeightHeight%A/HName18.65517,4852.2041842.064.18Butanoic acid, 2-amino-(CAS) 1-AMINOPROPANE-1-CARBOXYLIC ACID29.92237,8484.7712,7296.282.971,2-BENZOLDICARBONSAEURE. DI-(HEX-1EN-5-YL-ESTER)311.70718,4782.3359662.943.10Pentanoic acid, 4-methyl- (CAS) 4 -Methylvaleric acid412.57022,6472.8511,8865.861.912-Decen-1-o1(CAS)513.04915,8772.0085074.201.872-Chloro-2methyl-2heptane613.50339,1394.9315,9657.872.45Tetradecanoic acid, 12-methyl-, methyl ester (CAS)713.872132,10616.6536,13417.823.66Hexadecanoic acid (CAS) Palmitic acid814.05616,6742.1064333.172.591,2-Benzenedicarboxylic acid, bis (2-methylproyl) ester (CAS)915.14218,2182.3060873.002.994,4-Dimethylpentanenitrile1015.31953,4056.7311,0965.474.81CYCLOHEXANEMETHYL CROTONATE1115.40824,5363.0953362.634.601a-(endo)-chloro-2,5-epoxy-1a,2,5,5a-tetrahydro-2,5-dimethyl-5a-(endo)-1215.731175,32022.0930,62515.105.72DELTA-(3)-DODECANOL1315.86717,0922.1567583.332.531H-PYRROLE-3-CARBONITRILE1415.96734,8184.3958942.915.91NONANOIC ACID1518.50120,2252.5540802.014.96(R)-3,3-Dimethythoxy-2-(2,3-dihydrophytyloxy)-1propanol1621.73620,4382.5838091.885.372-((4-Phenylazo)phenyl)-3-oxo-4-methyl-5-imino-6-cyano-2,3,4,5-tetrahydor-1,2,4-triazine1722.24532,6414.1193694.623.48Silane,\[\[4--1,2-bis\[(trimethylsilyl)oxy\]ethyl\]-1,2-phenylen\]bis(oxy)\]bis\[trimethyl-(CAS)1822.50817,9512.2629581.466.072-PENTADECYL-4,4,5,5-TETRADEUTER1922.72455,5997.0110,7475.305.17Tetradecane, 2-methyl -(CAS) 2- Methyltetradecane2022.89423,0472.9041952.075.49Aziridine, 1-methyl- (CAS)1 -Methylaziridine793,544100.00202,758100.00Fig. 1Gas chromatography--mass spectrometry chromatogram of the methanolic extract of *Aloe castellorum*.Fig. 2Mass spectrum for the major constituent 9-octadecenoicacid from the methanolic extract of *Aloe castellorum*.Fig. 3Gas chromatography--mass spectrometry chromatogram of the methanolic extract of *Aloe pseudorubroviolacea*.Fig. 4Mass spectrum for major constituent 3-dodecenol of the methanolic extract of *Aloe pseudorubroviolacea*.

3.2. Cytotoxic activity {#s0075}
-----------------------

The plant extracts of *Aloe castellorum* and *Aloe pseudorubroviolacea* were evaluated for their cytotoxic activity examined against human colon cancer cell line (HCT-116). The methanol extracts of *Aloe castellorum*s shows 89.09% of cell viability at 20 µg/mL and *Aloe pseudorubroviolacea* shows 98.26% of cell viability at 20 µg/mL individually. The values are abridged in [Table 3](#t0015){ref-type="table"}, [Fig. 5](#f0025){ref-type="fig"} and [Table 4](#t0020){ref-type="table"}, [Fig. 6](#f0030){ref-type="fig"}. The effect of methanol extracts on apoptotic morphological changes in HCT 116 cell line were shown in [Fig. 7](#f0035){ref-type="fig"}. The effect of methanol extracts on Mitochondrial membrane potential of HCT 116 cell line were shown in [Fig. 8](#f0040){ref-type="fig"}. The effect of methanol extracts on ROS production in HCT 116 cells were shown in [Fig. 9](#f0045){ref-type="fig"}. The effect of methanolic extracts on HCT 116 cell morphology were shown in [Fig. 10](#f0050){ref-type="fig"}.Table 3Cytotoxic activity of *Aloe castellorum* extract against HCT-116 cell line.20 µg/ml40 µg/ml60 µg/ml80 µg/ml100 µg/ml150 µg/ml200 µg/ml250 µg/ml300 µg/mlMethanolic Extract 189.0961678.1911668.0982450.1165938.2835130.9748423.2021318.2136710.44096SD5.126832.0392813.833622.4362232.4362232.4362231.4065541.0632552.436223Fig. 5Cytotoxic activity of *Aloe castellorum* extract against HCT-116 cell line.Table 4Cytotoxic activity of *Aloe pseudorubroviolacea* extract against HCT-116 cell line.20 µg/ml40 µg/ml60 µg/ml80 µg/ml100 µg/ml150 µg/ml200 µg/ml250 µg/ml300 µg/mlMethanolic Extract 298.26193.5045782.4835669.0263256.6131940.4877132.8310120.5338815.42941SD5.6691111.5693631.9377594.3515583.1579624.5422274.5422272.2821984.195673Fig. 6Cytotoxic activity of *Aloe pseudorubroviolacea* extract against HCT-116 cell line.Fig. 7Ao/EtBr Staining explores the effect of Methanolic extracts on apoptotic morphological changes in HCT 116.Fig. 8Rhodamine 123 staining explores the effect of Methanolic extracts on Mitochondrial membrane potential of HCT 116 cells.Fig. 9DCF-DA staining explores the effect of Methanolic extracts on ROS production in HCT 116 cells.Fig. 10Effect of Methanolic extracts on HCT 116 cell morphology.

3.3. Docked results with AutoDock vina {#s0080}
--------------------------------------

The compounds **9-octadecenoicacid** and **3-dodecanol** were studied for their docking behavior with 3OGN protein via AutodockVina program. The compound **9-octadecenoicacid** shows good binding affinity (−3.3 kcal/mol) than **3-dodecanol** with the binding affinity of (−3.0 kcal/mol) in 2RS2 protein respectively. Hydrogen bonding is one of the significant factor in the stability of protein-ligand bonding, and the favorable bond distance amongst the H-donor and the H-acceptor atoms is less than 3.5 Å ([@b0100]). The hydrogen bond distances of compounds **9-octadecenoicacid** and **3-dodecanol** were less than 3.5 Å in respective 2RS2 protein signifies strong hydrogen bonding. Compound **9-octadecenoicacid** forms only one Hydrogen bond interaction with the receptor 2RS2. The amino acid residue Arg61 (bond length: 2.29) was involved in hydrogen bonding contact. The amino acid residues Arg61 and A 106 were involved in hydrophobic interactions. The interactions of compound **9-octadecenoicacid** with 2RS2 protein were shown in [Fig. 11](#f0055){ref-type="fig"}. The compound **3-dodecanol** forms only one hydrogen bonds with the receptor 2RS2. The amino acid residue Arg59 (bond length: 2.36) was involved in hydrogen bonding contact. The amino acid residues Arg59 and Arg61 were involved in hydrophobic interactions. The interactions of compound **3-dodecanol** with 2RS2 protein were shown in [Fig. 12](#f0060){ref-type="fig"}. The results shows that compound **9-octadecenoicacid** having remarkable inhibition ability than compound **3-dodecanol** in anticancer protein 2RS2. The results were summarized in [Table 5](#t0025){ref-type="table"}.Fig. 11Docked complex (a), molecular surface (b), 3D (c), and 2D (d) interaction modes of compound **9-octadecenoicacid** within the binding site of 2RS2 protein.Fig. 12Docked complex (a), molecular surface (b), 3D (c), and 2D (d) interaction modes of compound **3-dodecanol** within the binding site of 2RS2 protein.Table 5Molecular docking interaction of compounds **9-octadecenoicacid** and **3-dodecanol** against protein 2RS2.**Compounds**Mosquito odorant binding protein 3OGNBinding affinity (kcal/mol)No. of H-bondsH-bonding residues**9-octadecenoicacid**−3.31Arg61**3-dodecanol**−3.01Arg59

4. Conclusions {#s0085}
==============

The conclusion of this study, which includes the extraction of phytochemical constituents from medicinal plants *Aloe castellorum* and *Aloe pseudorubroviolacea.* The methanolic extract of particular plants were further studied for their cytotoxic activity against human colon cancer cell line (HCT-116). The two plant extracts having significant cytotoxic activity, meanwhile the methanolic extract of *Aloe castellorum* shows higher cytotoxic activity than *Aloe pseudorubroviolacea* extract. The effect of apoptotic morphological changes, Mitochondrial membrane potential, ROS production, and cell morphology on HCT-116 cell line are also assessed. Therefore, the methanolic extracts of medicinal plants *Aloe castellorum* and *Aloe pseudorubroviolacea* having potential cytotoxic chemical constituents itself for the development of new era cytotoxic drugs for colon cancer.
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